Loading...
IRADIMED Community
NasdaqGM:IRMD Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
Community Investing Ideas
IRMD: Index Addition and Strong Margins Will Support Measured Upside
Key Takeaways Enhanced usability and technology in the new MRI-compatible IV pump are expected to drive major replacement cycles and expand the customer base. Aging populations and higher MRI volumes support sustained demand, while operational investments and strong pricing power boost margins and revenue visibility.Read more
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$99
5.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
10.14% p.a.
Profit Margin
28.38%
Future PE
48.61x
Price in 2028
US$116.49
